Trial Profile
Correlation between fatigue and quality of life in patients with hematological malignancies treated with biosimilar epoetin alfa (Sandoz) for chemotherapy induced anemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2019
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Acronyms the Ciroco Study
- 22 Jul 2018 New trial record
- 17 Jun 2018 Results (n=104) presented at the 23rd Congress of the European Haematology Association.